Taking the lead: Astria Therapeutics Inc (ATXS)

With 0.87 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.36 million shares. The 52-week range on ATXS shows that it touched its highest point at $12.92 and its lowest point at $3.56 during that stretch. It currently has a 1-year price target of $28.78. Beta for the stock currently stands at 0.43.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ATXS was down-trending over the past week, with a drop of -14.73%, but this was up by 17.33% over a month. Three-month performance dropped to -40.94% while six-month performance fell -61.87%. The stock lost -54.96% in the past year, while it has lost -50.78% so far this year. A look at the trailing 12-month EPS for ATXS yields -1.69 with Next year EPS estimates of -2.07. For the next quarter, that number is -0.48. This implies an EPS growth rate of -14.95% for this year and -6.97% for next year. EPS is expected to decline by -5.48% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 34.65%.

Float and Shares Shorts:

At present, 56.43 million ATXS shares are outstanding with a float of 46.42 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ATXS since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.49908 being high and -$1.78658 being low. For ATXS, this leads to a yearly average estimate of -$1.69417.